Abstract
Estimating the burden of COVID-19 in India is difficult because the extent to which cases and deaths have been undercounted is hard to assess. The INDSCI-SIM model is a 9-component, age-stratified, contact-structured compartmental model for COVID-19 spread in India. We use INDSCI-SIM, together with Bayesian methods, to obtain optimal fits to reported cases and deaths across the span of the first wave of the Indian pandemic, over the period Jan 30, 2020 to Feb 15, 2021. We account for lock-downs and other non-pharmaceutical interventions, an overall increase in testing as a function of time, the under-counting of cases and deaths, and a range of age-specific infection-fatality ratios. We first use our model to describe data from all individual districts of the state of Karnataka, benchmarking our calculations using data from serological surveys. We then extend this approach to aggregated data for Karnataka state. We model the progress of the pandemic across the cities of Delhi, Mumbai, Pune, Bengaluru and Chennai, and then for India as a whole. We estimate that deaths were undercounted by a factor between 2 and 5 across the span of the first wave, converging on 2.2 as a representative multiplier that accounts for the urban-rural gradient across the country. We also estimate an overall under-counting of cases by a factor of between 20 and 25 towards the end of the first wave. Our estimates of the infection fatality ratio (IFR) are in the range 0.05 - 0.15, broadly consistent with previous estimates but substantially lower than values that have been estimated for other LMIC countries. We find that approximately 40% of India had been infected overall by the end of the first wave, results broadly consistent with those from serosurveys. These results contribute to the understanding of the long-term trajectory of COVID-19 in India.
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
SMS acknowledges funding from the DST-INSPIRE Faculty Fellowship (DST/INSPIRE/04/2018/002664) by DST India. GIM thanks the Department of Biological Science, TIFR (Mumbai) for an Adjunct Professorship and acknowledges support of the Bill and Melinda Gates Foundation, Grant No: R/BMG/PHY/GMN/20
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
Since this work reports results of modeling only and reproduces only publicly available data, no IRB approval was sought.
All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.
Yes
Data Availability
We developed a fast FORTRAN code (ELiXSIR) - Extended, zone Linked IX-compartmental SIR model: a code to simulate COVID19 infection} as a solver for the model. A version of ELiXSIR is available for download in https://gitlab.com/dhirajhazra/eSIR_INDIA. The code is designed for arbitrary numbers of age groups and regions. We acknowledge the use of PolyChord through the publicly available code CosmoChord: https://github.com/williamjameshandley/CosmoChord. ELiXSIR is fused with CosmoChord for the purpose of data analysis and post processing.